B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Zanamivir

297 PubMed studies analyzed · 31 RCTs · Evidence Score: 50.7

Research Domains

Zanamivir has been studied across 10 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🫁 Respiratory, 🔬 Oncology, ⏳ Longevity & Aging. The primary research focus is 🫘 Kidney with 6% of studies addressing this area.

Loading evidence profile...

This evidence profile for Zanamivir is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.